In terms of single organ metastasis, EGFR mutant NSCLC prefer to transfer to bone, brain, and lung, with L858R mutation patients mostly developing bone and brain metastasis, 19Del mutation patients mostly developing intrapulmonary, pleural, and bone metastasis. This evidence concerns the gene EGFR and non-small cell lung carcinoma.